These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Methylprednisolone-induced toxic hepatitis. Topal F; Ozaslan E; Akbulut S; Küçükazman M; Yüksel O; Altiparmak E Ann Pharmacother; 2006 Oct; 40(10):1868-71. PubMed ID: 16926305 [TBL] [Abstract][Full Text] [Related]
44. Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis? Teschke R; Eickhoff A; Schulze J J Clin Transl Hepatol; 2013 Sep; 1(1):59-74. PubMed ID: 26357608 [TBL] [Abstract][Full Text] [Related]
45. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality? Teschke R; Schmidt-Taenzer W; Wolff A Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069 [TBL] [Abstract][Full Text] [Related]
46. Drug-induced liver injury in the Australian setting. Sistanizad M; Peterson GM J Clin Pharm Ther; 2013 Apr; 38(2):115-20. PubMed ID: 23350857 [TBL] [Abstract][Full Text] [Related]
47. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Teschke R Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694 [TBL] [Abstract][Full Text] [Related]
48. Drug-Induced Liver Failure Requiring Liver Transplant: Report and Review of the Role of Albendazole in Managing Echinococcal Infection. Aasen TD; Nasrollah L; Seetharam A Exp Clin Transplant; 2018 Jun; 16(3):344-347. PubMed ID: 27228108 [TBL] [Abstract][Full Text] [Related]
49. Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran. Lewis JH; Larrey D; Olsson R; Lee WM; Frison L; Keisu M Int J Clin Pharmacol Ther; 2008 Jul; 46(7):327-39. PubMed ID: 18793587 [TBL] [Abstract][Full Text] [Related]
50. A Rise in Aspartate Transaminase and Alanine Transaminase Associated With Ondansetron Administration in a Pregnant Female. Couse M; Syed S Cureus; 2020 Nov; 12(11):e11540. PubMed ID: 33365209 [TBL] [Abstract][Full Text] [Related]
52. [Clinical and pathological features in 138 cases of drug-induced liver injury]. Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136 [TBL] [Abstract][Full Text] [Related]
57. Erlotinib-induced hepatitis complicated by fatal lactic acidosis in an elderly man with lung cancer. Pellegrinotti M; Fimognari FL; Franco A; Repetto L; Pastorelli R Ann Pharmacother; 2009 Mar; 43(3):542-5. PubMed ID: 19261961 [TBL] [Abstract][Full Text] [Related]
58. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Duzenli T; Tanoglu A; Akyol T; Kara M; Yazgan Y Euroasian J Hepatogastroenterol; 2019; 9(1):49-51. PubMed ID: 31988867 [TBL] [Abstract][Full Text] [Related]
59. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Teschke R; Schulze J; Eickhoff A; Danan G Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242 [TBL] [Abstract][Full Text] [Related]